Indian Market News

Generic user silhouette icon 5paisa Capital Ltd
  • 30th Sep 2025
  • 2 min read

India’s largest mutual fund, SBI Mutual Fund, is shifting its fixed income stance by favouring short- and medium-term government bonds over ultra-long duration debt. This change comes even as the government has altered its bond issuance mix, reduci

Generic user silhouette icon 5paisa Capital Ltd
  • 30th Sep 2025
  • 2 min read

The Securities and Exchange Board of India (SEBI) will roll out a series of stricter rules for the equity derivatives (F&O) segment from October 1, 2025, aimed at curbing excessive speculation and enhancing market stability. The new framework int

Generic user silhouette icon 5paisa Capital Ltd
  • 30th Sep 2025
  • 2 min read

The Indian rupee opened on a positive note on Monday, September 30, strengthening by 6 paise against the U.S. dollar, even as most Asian currencies faced downward pressure. The currency began trading at 88.6975 per dollar, compared with the previous

Generic user silhouette icon 5paisa Capital Ltd
  • 29th Sep 2025
  • 2 min read

The buoyant Indian primary market is set to see another wave of public offerings as four companies—Laser Power and Infra Ltd (LPIL), Indo MIM Ltd, Behari Lal Engineering Ltd, and Alcobrew Distilleries India Ltd—have submitted draft papers with th

Generic user silhouette icon 5paisa Capital Ltd
  • 29th Sep 2025
  • 2 min read

Rating Reaffirmed on Fiscal and Growth Balance Global rating agency Moody’s on September 29 reaffirmed India’s long-term local and foreign-currency issuer ratings, as well as its local-currency senior unsecured rating, at Baa3. The outlook has

Generic user silhouette icon 5paisa Capital Ltd
  • 29th Sep 2025
  • 2 min read

RBI MPC Set to Meet Amid Split Views on Rate Action The Reserve Bank of India’s (RBI) Monetary Policy Committee (MPC) is scheduled to meet from September 29 to October 1, 2025, amid growing debate over the possibility of a rate cut. Economists a

Generic user silhouette icon 5paisa Capital Ltd
  • 29th Sep 2025
  • 2 min read

India’s primary market is poised for a record-breaking 2025, with IPO fundraising set to surpass the ₹1 lakh crore mark even as three months remain in the year. So far, 74 initial public offerings have collectively raised approximately ₹85,000

Generic user silhouette icon 5paisa Capital Ltd
  • 29th Sep 2025
  • 2 min read

Tata Capital, the flagship financial services arm of the Tata Group, has reduced its post-money equity valuation ahead of its highly anticipated initial public offering (IPO), according to moneycontrol. The decision, taken over the weekend, is being

Generic user silhouette icon 5paisa Capital Ltd
  • 26th Sep 2025
  • 2 min read

The Reserve Bank of India (RBI) did not buy U.S. dollars from the foreign exchange market in July 2025, marking the first such instance in more than 11 years. Instead, the central bank sold $2.54 billion during the month to control volatility as the

Generic user silhouette icon 5paisa Capital Ltd
  • 26th Sep 2025
  • 2 min read

The Securities and Exchange Board of India (SEBI) is reviewing how brokers manage their exposure to index derivatives to reduce market risk and prevent excessive concentration. According to people familiar with the matter, the regulator is considerin

Generic user silhouette icon 5paisa Capital Ltd
  • 26th Sep 2025
  • 2 min read

Indian equity markets closed the week on a weaker note as small-cap and mid-cap indices continued their downward streak for the fifth straight session on Friday. The persistent decline mirrored the broader weakness in the benchmark Sensex and Nifty,

Generic user silhouette icon 5paisa Capital Ltd
  • 26th Sep 2025
  • 2 min read

Indian pharmaceutical stocks witnessed a sharp decline on Friday, September 26, after the United States announced steep tariffs on imported drugs. The Nifty Pharma index dropped 2% over the past month, with leading companies such as Cipla, Divi’s L

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form